Raptor Metals Ltd (ASX: RAP) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
Raptor Metals Ltd Chart and Price Data
Fundamentals Data provided by Morningstar.
Data provided by Morningstar.
Market Cap
$14.83 million
P/E Ratio
N/A
Dividend Yield
0.00%
Shares Outstanding
616.10 million
Earnings per share
-0.015
Dividend per share
N/A
Year To Date Return
291.62%
Earnings Yield
N/A
Franking
-
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
Raptor Metals Ltd (ASX: RAP)
Latest News
Healthcare Shares
Why is the ResApp share price lifting today?
Mergers & Acquisitions
ResApp share price explodes 50% on new Pfizer deal
Share Fallers
Why Bowen Coking Coal, Lake Resources, Premier, and ResApp shares are tumbling lower
Mergers & Acquisitions
Why is the ResApp share price crashing 29% today?
Healthcare Shares
ResApp share price frozen as $180m Pfizer takeover bid hangs in the balance
Share Market News
This ASX share is defying the odds to crack new 52-week highs
Share Gainers
Why Computershare, Lithium Plus, Lynas, and ResApp shares are pushing higher
Mergers & Acquisitions
Here's why the ResApp share price is rocketing 50% today
Share Gainers
Why Australian Clinical Labs, Lake Resources, PolyNovo, and ResApp are rising
Mergers & Acquisitions
ResApp share price halted ahead of Pfizer takeover update
Share Gainers
Why IGO, Lake Resources, Regis Resources, and ResApp shares are charging higher
Healthcare Shares
ResApp share price rockets 28% on Pfizer takeover news
RAP ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About Raptor Metals Ltd
ResApp is developing digital healthcare solutions to assist doctors and empower patients to diagnose and manage respiratory disease. We are creating easy to use, affordable, clinically-validated and regulatory-approved diagnostic tools that only require a smartphone. Our solutions are designed to be easily integrated into existing telehealth solutions and we are also working on apps to provide respiratory disease diagnosis and management directly to consumers and healthcare providers. ###Narhex Life Sciences Ltd has completed the acquisition of ResApp Diagnostics Pty Ltd and will now change its name to ResApp Health.###
RAP Share Price History Data provided by Morningstar.
| Date | Close | Change | % Change | Volume | Open | High | Low |
|---|---|---|---|---|---|---|---|
| 20 Mar 2026 | $0.04 | $0.00 | 0.00% | 2,004,160 | $0.04 | $0.04 | $0.03 |
| 19 Mar 2026 | $0.04 | $0.00 | 0.00% | 1,082,759 | $0.04 | $0.04 | $0.04 |
| 18 Mar 2026 | $0.04 | $0.00 | 0.00% | 1,254,140 | $0.04 | $0.04 | $0.04 |
| 17 Mar 2026 | $0.04 | $0.00 | 0.00% | 344,529 | $0.04 | $0.04 | $0.04 |
| 16 Mar 2026 | $0.04 | $0.00 | 0.00% | 413,148 | $0.05 | $0.05 | $0.04 |
| 13 Mar 2026 | $0.05 | $0.00 | 0.00% | 1,016,717 | $0.05 | $0.05 | $0.05 |
| 12 Mar 2026 | $0.05 | $0.00 | 0.00% | 2,050,025 | $0.05 | $0.05 | $0.05 |
| 11 Mar 2026 | $0.05 | $0.01 | 22.73% | 3,224,316 | $0.05 | $0.05 | $0.05 |
| 10 Mar 2026 | $0.04 | $0.00 | 0.00% | 3,753,639 | $0.04 | $0.05 | $0.04 |
| 09 Mar 2026 | $0.04 | $0.00 | 0.00% | 3,494,408 | $0.04 | $0.04 | $0.03 |
| 06 Mar 2026 | $0.04 | $0.00 | 0.00% | 3,154,700 | $0.05 | $0.05 | $0.04 |
| 05 Mar 2026 | $0.05 | $0.00 | 0.00% | 1,242,589 | $0.05 | $0.05 | $0.05 |
| 04 Mar 2026 | $0.05 | $-0.01 | -18.87% | 2,272,332 | $0.05 | $0.05 | $0.05 |
| 03 Mar 2026 | $0.05 | $0.00 | 0.00% | 1,908,988 | $0.05 | $0.06 | $0.05 |
| 02 Mar 2026 | $0.06 | $0.00 | 0.00% | 68,805 | $0.05 | $0.06 | $0.05 |
| 27 Feb 2026 | $0.05 | $0.00 | 0.00% | 1,191,979 | $0.06 | $0.06 | $0.05 |
| 26 Feb 2026 | $0.06 | $0.00 | 0.00% | 723,770 | $0.06 | $0.06 | $0.05 |
| 25 Feb 2026 | $0.06 | $0.00 | 0.00% | 3,520,946 | $0.06 | $0.06 | $0.05 |
| 24 Feb 2026 | $0.06 | $0.00 | 0.00% | 4,108,045 | $0.05 | $0.06 | $0.05 |
| 23 Feb 2026 | $0.05 | $0.00 | 0.00% | 1,558,405 | $0.05 | $0.06 | $0.05 |
| 20 Feb 2026 | $0.05 | $0.00 | 0.00% | 3,630,123 | $0.06 | $0.06 | $0.05 |
Director Transactions Data provided by Morningstar.
| Date | Director | Type | Amount | Value | Notes |
|---|---|---|---|---|---|
| 22 Dec 2025 | Ian White | Issued | 500,000 | $5,000 |
Director remuneration.
|
Directors & Management Data provided by Morningstar.
| Name | Title | Start Date | Profile |
|---|---|---|---|
| Mr Ian Keith White | Non-Executive Director | Oct 2022 |
Mr White has 45 years of corporate experience including more than 23 years as Director and Company Secretary. Ian is experienced in all areas of corporate management. He is particularly experienced in all aspects of corporate financial reporting and corporate governance. Ian was a key advisor to WPG Resources Limited during its development and subsequent $320M sale of its Peculiar Knob project and has worked in Canada and China. Ian is at present a Director of Professional Edge Pty Ltd, a legal and financial services provider of listed and unlisted companies, with emphasis on the junior resources sector.
|
| Mr Adam James Sierakowski | Non-Executive ChairmanNon-Executive Director | Dec 2025 |
Mr Sierakowski is a founder of Price Sierakowski and Trident Capital focusing on corporate
transactions from private to listed public entities. Mr Sierakowski has experience in corporate advisory, capital raisings, ASX transactions including developing assets and corporate structures for major companies both in Australia and overseas. Mr Sierakowski has over 20 years of experience as a Director of ASX listed companies. |
| Mr Brett Wallace | Managing Director | Dec 2025 |
Mr Wallace with 20 years experience in all aspects of geology from green-fields exploration through to mine geology and grade control, across a diverse range of commodities including copper, gold, nickel and iron ore. Mr Wallace
was admitted as a solicitor in August 2004 and practiced in the areas of major projects and mining law, with particular experience in large scale projects and mining infrastructure related contracts primarily within the oil and gas and mining sectors. He has acted as a solicitor and consultant at DLA Piper and as In-house Legal Counsel for ASX listed companies and previously held positions with ASX listed companies as managing director, non-executive director and company secretary. |
| Mrs Amanda Wilton Heald | Company Secretary | Dec 2025 |
-
|
| Amanda Wilton Heald | Company Secretary |
-
|
Top Shareholders Data provided by Morningstar.
| Name | Shares | Capital |
|---|---|---|
| REC Investment Management Pty Ltd | 16,398,667 | 11.76% |
| Ocean Reef Holdings Pty Ltd | 5,150,000 | 3.69% |
| Fairbrother Holdings Pty Ltd | 3,834,956 | 2.75% |
| Scintilla Strategic Investments Limited | 3,800,000 | 2.73% |
| Khe Sanh Pty Ltd <Trading No 1 A/C> | 3,750,000 | 2.69% |
| Mr Scott Robert Weir <The S R Investment A/C> | 3,604,519 | 2.59% |
| Sailors of Samui Pty Ltd | 3,300,000 | 2.37% |
| Bullseye Geoservices Pty Ltd <Haynes Family A/C> | 3,068,851 | 2.20% |
| Aquiline Nominees Pty Ltd <The Aquiline Family A/C> | 2,600,000 | 1.86% |
| Aymon Pacific Pty Ltd <Jerezos A/C> | 2,500,000 | 1.79% |
| Capmack Investments Pty Ltd | 2,500,000 | 1.79% |
| Traditional Securities Group Pty Ltd <LPR Family A/C> | 2,500,000 | 1.79% |
| Longridge Partners Pty Ltd | 2,499,998 | 1.79% |
| Gary James Jones | 2,275,000 | 1.63% |
| Mr Ian Michael Paterson Parker | 2,000,000 | 1.43% |
| PCAS (Australia) Pty Ltd <PCAS Investment No 2 A/C> | 2,000,000 | 1.43% |
| Rubenalbus Pty Ltd <MIP Super A/C> | 2,000,000 | 1.43% |
| Irrawaddy Investments Pty Ltd <Duffin Family A/C> | 1,936,712 | 1.39% |
| Mr Philip Umberto Re | 1,850,000 | 1.33% |
| Mr Syed Mushleh Uddin | 1,750,000 | 1.26% |
| Calama Holdings Pty Ltd <Mambat Super Fund A/C> | 1,715,000 | 1.23% |
| Symington Pty Ltd | 1,700,000 | 1.22% |
| Puntero Pty Ltd | 1,500,000 | 1.08% |
| Budworth Capital Pty Ltd <Rolling Hills Capital A/C> | 1,355,481 | 0.97% |